| Oct 24 |
Dexcom stock tumbles 16% post-market amid Q3 earnings report (update)
|
| Oct 24 |
Glucose monitor maker Dexcom beats quarterly sales estimates, backs annual forecast
|
| Oct 24 |
DexCom Q3 earnings beat estimates, but stock tumbles 16% on weak growth
|
| Oct 24 |
DexCom: Q3 Earnings Snapshot
|
| Oct 24 |
DexCom Non-GAAP EPS of $0.45 beats by $0.02, revenue of $994.2M beats by $3.01M
|
| Oct 24 |
Dexcom Reports Third Quarter 2024 Financial Results
|
| Oct 23 |
DexCom Q3 2024 Earnings Preview
|
| Oct 23 |
US Stocks That May Be Priced Below Intrinsic Value Estimates In October 2024
|
| Oct 22 |
Will CGM Sensor Demand Continue to Drive DexCom Q3 Earnings?
|
| Oct 22 |
Jim Cramer Calls AST SpaceMobile 'Overvalued,' Warns HubSpot Is 'Playing With Fire'
|
